Treatment of Hypocalcemia

Assessment and Indications for Treatment

The American College of Physicians recommends treatment when serum calcium is below 8.4 mg/dL with clinical symptoms including paresthesia, positive Chvostek's and Trousseau's signs, bronchospasm, laryngospasm, tetany, or seizures 1
Hypocalcemia can be asymptomatic or present with fatigue, emotional irritability, abnormal involuntary movements, seizures, and cardiac arrhythmias (including prolongation of the QT interval) 2, 3
Regular investigations should include measurements of pH-corrected ionized calcium, magnesium, parathyroid hormone, and creatinine concentrations 2, 3

Calcium chloride is preferred over calcium gluconate in emergency situations, as 10 mL of 10% calcium chloride contains 270 mg of elemental calcium compared to only 90 mg in 10 mL of 10% calcium gluconate 4

The National Kidney Foundation recommends daily calcium and vitamin D supplementation for long-term management 2, 3, 1
Oral calcium supplementation with calcium carbonate is the preferred calcium salt for chronic management 1
Total elemental calcium intake (dietary + supplements) should not exceed 2,000 mg/day 5, 1
For patients with hypoparathyroidism or more severe hypocalcemia, active vitamin D metabolites (calcitriol, alfacalcidol) may be required 1
Magnesium supplementation is indicated for those with concurrent hypomagnesemia 2, 3, 1

For patients with chronic kidney disease, the National Kidney Foundation recommends maintaining serum calcium within the normal laboratory range, preferably toward the lower end (8.4 to 9.5 mg/dL) 5, 1
Monitor serum phosphorus levels to maintain calcium-phosphorus product at <55 mg²/dL² 5

Avoid over-correction, which can result in iatrogenic hypercalcemia, renal calculi, and renal failure 3, 1
Hypocalcemia risk increases with biological stress (surgery, childbirth, infection) 2, 3
Hypocalcemia may be worsened by alcohol or carbonated beverages such as colas 2
For patients with liver dysfunction, calcium chloride may be preferable to calcium gluconate due to decreased citrate metabolism in these patients 4

The National Kidney Foundation recommends that for patients with hypoparathyroidism or more severe hypocalcemia, active vitamin D metabolites (calcitriol or alfacalcidol) may be required, with an initial dose of calcitriol at 20–30 ng/kg body weight daily or alfacalcidol at 30–50 ng/kg body weight daily 6
According to the National Kidney Foundation, treatment with calcitriol or alfacalcidol can be started empirically at 0.5 μg daily of calcitriol or 1 μg of alfacalcidol in patients >12 months old 6

The National Kidney Foundation recommends avoiding hypercalcemia in adult CKD patients, and using dialysate calcium concentration between 1.25 and 1.50 mmol/L for patients on dialysis 7
The American College of Physicians suggests an individualized approach for hypocalcemia, correcting significant or symptomatic hypocalcemia, but routine correction of mild hypocalcemia is not universally recommended 7
The Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommends monitoring calcium-phosphorus product and maintaining it at <55 mg²/dL², although the specific citation for this is not provided, the guideline society is mentioned in the context of CKD management 7